Rayence Co. Ltd Asset Resilience Ratio

Latest as of June 2026: 38.97%

Rayence Co. Ltd asset resilience ratio. Rayence Co. Ltd (228850) has an Asset Resilience Ratio of 38.97% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Rayence Co. Ltd to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩106.00 Billion
≈ $71.83 Million USD Cash + Short-term Investments

Total Assets

₩271.97 Billion
≈ $184.31 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio of Rayence Co. Ltd (2016–2025)

Asset resilience ratio of Rayence Co. Ltd from 2016 to 2025. This chart shows how Rayence Co. Ltd's Asset Resilience Ratio has changed over time. Read Rayence Co. Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Rayence Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Rayence Co. Ltd total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩106.00 Billion 38.97%
Total Liquid Assets ₩106.00 Billion 38.97%

Asset Resilience Insights

  • Very High Liquidity: Rayence Co. Ltd maintains exceptional liquid asset reserves at 38.97% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Rayence Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Rayence Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
T&L Co. Ltd
KQ:340570
Medical Devices 26.03%
Paxman AB
ST:PAX
Medical Devices -3.83%
VIROMED MEDICAL NA O.N.
XETRA:VME
Medical Devices 0.03%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.48%
Pulsenmore Ltd
TA:PULS
Medical Devices 51.61%
Geratherm Medical AG
XETRA:GME
Medical Devices 34.89%

Rayence Co. Ltd Asset Resilience Ratio by Year (2016–2025)

Rayence Co. Ltd asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Rayence Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 39.81% ₩104.00 Billion
≈ $70.48 Million
₩261.22 Billion
≈ $177.02 Million
-15.98pp
2024-12-31 55.79% ₩150.21 Billion
≈ $101.79 Million
₩269.22 Billion
≈ $182.44 Million
+2.22pp
2023-12-31 53.57% ₩148.65 Billion
≈ $100.74 Million
₩277.49 Billion
≈ $188.05 Million
+3.67pp
2022-12-31 49.90% ₩130.73 Billion
≈ $88.59 Million
₩262.00 Billion
≈ $177.55 Million
+0.96pp
2021-12-31 48.94% ₩118.33 Billion
≈ $80.19 Million
₩241.80 Billion
≈ $163.86 Million
+3.79pp
2020-12-31 45.15% ₩101.45 Billion
≈ $68.75 Million
₩224.72 Billion
≈ $152.29 Million
+6.72pp
2019-12-31 38.43% ₩89.18 Billion
≈ $60.43 Million
₩232.07 Billion
≈ $157.27 Million
-4.47pp
2018-12-31 42.89% ₩86.27 Billion
≈ $58.46 Million
₩201.13 Billion
≈ $136.30 Million
-3.03pp
2017-12-31 45.92% ₩90.21 Billion
≈ $61.13 Million
₩196.45 Billion
≈ $133.13 Million
+1.21pp
2016-12-31 44.71% ₩85.12 Billion
≈ $57.68 Million
₩190.36 Billion
≈ $129.00 Million
--
pp = percentage points

About Rayence Co. Ltd

KQ:228850 Korea Medical Devices
Market Cap
$82.86 Million
₩122.27 Billion KRW
Market Cap Rank
#19742 Global
#1018 in Korea
Share Price
₩7770.00
Change (1 day)
+1.04%
52-Week Range
₩4895.00 - ₩8610.00
All Time High
₩20930.72
About

Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-… Read more